Simpson Joy, Smith Andrew D, Fraser Abigail, Sattar Naveed, Callaway Mark, Lindsay Robert S, Lawlor Debbie A, Nelson Scott M
School of Medicine (J.S., S.M.N.), University of Glasgow, Glasgow G31 2ER, United Kingdom; Medical Research Council Integrative Epidemiology Unit (A.D.S., A.F., D.A.L.), School of Social and Community Medicine (A.D.S., A.F., D.A.L.), University of Bristol, Bristol BS13NY United Kingdom; Institute of Cardiovascular and Metabolic Medicine (N.S., R.S.L.), British Heart Foundation Glasgow Cardiovascular Research Centre, Glasgow G61 1QH, United Kingdom; and University Hospitals Bristol National Health Service Foundation Trust (M.C.), Bristol BS1 3NY, United Kingdom.
J Clin Endocrinol Metab. 2016 Dec;101(12):4661-4668. doi: 10.1210/jc.2016-2604. Epub 2016 Sep 20.
Maternal adiposity in pregnancy is associated with offspring adiposity and metabolic dysfunction postnatally, including greater risk of nonalcoholic fatty liver disease (NAFLD). Recent genetic analyses suggest a causal effect of greater maternal body mass index on offspring birth weight and ponderal index, but the relative roles of the environment in utero or later in life remains unclear.
We sought to determine whether markers of infant adiposity (birth weight, umbilical cord blood leptin, adiponectin, and lipids) were associated with markers of NAFLD in adolescence.
DESIGN, SETTING, AND PARTICIPANTS: This was a UK prospective birth cohort with 17 years of follow-up with liver function tests (aspartate aminotransferase, alanine aminotransferase, gamma-glutamyltransferase) (n = 1037 participants), and ultrasound scan assessed liver fat, volume, and sheer velocity at age 17 (n = 541 participants). Missing covariate data were imputed.
Ultrasound and biochemical measures of NAFLD were measured.
Birth weight, cord blood leptin, and adiponectin were not associated with a diagnosis of NAFLD. In adjusted analyses, 2 of 42 associations attained conventional 5% levels of significance. Birth weight was positively associated with liver volume (1.0% greater per 100 g [95% confidence interval 0.5%-2.0%]). Cord high-density lipoprotein-cholesterol was positively associated with alanine aminotransferase (11.6% higher per 1 mmol/L [95% confidence interval 0.3, 23.4]); however, this association was primarily mediated via offspring adiposity.
In this extensive analysis, we found little evidence measurements of infant fat mass and birth size were related to adolescent markers of NAFLD. The association between birth weight and adolescent liver volume may indicate the contribution of greater organ size to birth weight and tracking of organ size.
孕期母体肥胖与子代出生后肥胖及代谢功能障碍有关,包括非酒精性脂肪性肝病(NAFLD)风险增加。近期的基因分析表明,母体体重指数较高对子代出生体重和 ponderal 指数有因果效应,但子宫内环境或生命后期环境的相对作用仍不清楚。
我们试图确定婴儿肥胖指标(出生体重、脐带血瘦素、脂联素和脂质)是否与青少年 NAFLD 指标相关。
设计、地点和参与者:这是一项英国前瞻性出生队列研究,对 1037 名参与者进行了 17 年的肝功能测试(天冬氨酸转氨酶、丙氨酸转氨酶、γ-谷氨酰转移酶)随访,并对 541 名 17 岁参与者进行了超声扫描评估肝脏脂肪、体积和剪切波速度。缺失的协变量数据进行了插补。
测量 NAFLD 的超声和生化指标。
出生体重、脐带血瘦素和脂联素与 NAFLD 诊断无关。在调整分析中,42 种关联中有 2 种达到了传统的 5% 显著性水平。出生体重与肝脏体积呈正相关(每增加 100 g,肝脏体积增加 1.0% [95% 置信区间 0.5%-2.0%])。脐带高密度脂蛋白胆固醇与丙氨酸转氨酶呈正相关(每增加 1 mmol/L,丙氨酸转氨酶升高 11.6% [95% 置信区间 0.3, 23.4]);然而,这种关联主要通过子代肥胖介导。
在这项广泛的分析中,我们几乎没有发现婴儿脂肪量和出生大小的测量值与青少年 NAFLD 指标相关的证据。出生体重与青少年肝脏体积之间的关联可能表明更大的器官大小对出生体重的贡献以及器官大小的追踪。